September 2008 October 2008 R Dirty Pending Final 1 101 พระพุทธบาท

Total Page:16

File Type:pdf, Size:1020Kb

September 2008 October 2008 R Dirty Pending Final 1 101 พระพุทธบาท September 2008 October 2008 November 2008 No Site No. Hospital Name Record Status Total Cases Total Cases Total Cases Total Records r Dirty Pending Final 1 101 พระพุทธบาท สระบุรี Phraphuthabat Hospital 1129126 2 102 พญาไท ศรีราชา ชลบุรี Phyathai Sriracha Hospital 0116501 3 103 เวชศาสตรเขตรอน The Hospital for Tropical Medicine 0000000 4 104 ระยอง Rayong Hospital 155204016 5 105 รวมแพทยระยอง Ruampat Rayong 0000000 6 106 คลีนิคแพทยสุชาดา ระยอง Suchada Clinic 0000000 7 107 สงขลา Songkhla Hospital 0014202 8 108 สรรพสิทธิประสงค อุบลราชธานี Sapasittiprasong Hospital 10 21 30 120 19128 9 109 พระรามเกา Praram 9 Hospital 0000000 10 110 บําราศนราดูร นนทบุรี Bamrasnaradura Infectious Diseases Institute 0116132 11 111 ชลบุรี Chonburi Hospital 023120012 12 112 ธรรมศาสตรเฉลิมพระเกียรติ ปทุมธานี Thammasat University Hospital 0228017 13 113 เจาพระยา Chaophya Hospital 0000000 14 114 สงขลานครินทร สงขลา Songkhlanakarin Hospital 00416547 15 115 มูลนิธิโรคไต ณ โรงพยาบาลสงฆ The Kidney Foundation of Thailand 0000000 16 116 นพรัตนราชธานี Nopprat Rajathanee Hospital 036240717 17 117 พระจอมเกลา เพชรบุรี Phra Chom Klao Hospital Petburi 0000000 18 118 พระมงกุฎเกลา (กุมาร) Phramongkutklao Hospital, (Pediatrics) 0000000 19 119 สุราษฎรธานี Surat Thani Hospital 12 12 14 55 1054 20 120 รามาธิบดี Ramathibodi Hospital 0000000 21 121 วชิรพยาบาล Vajira Hospital 1112020 22 122 บานแพว สมุทรสาคร Banphaeo Hospital 1116501 23 123 สวรรคประชารักษ นครสวรรค Sawanpracharak Hospital 00312066 24 124 จุฬาลงกรณ Chulalongkorn Hospital 18 19 20 79 26 35 18 25 125 บํารุงราษฎร Bumrungrad International 0000000 26 126 ทักษิณ สุราษฎรธานี Thaksin Hospital 0000000 27 127 คายวิภาวดีรังสิต Fort Wiphavadirangsit Hospital 22215771 28 128 พระนครศรีอยุธยา Pranakornsriayudhaya Hospital 0000000 29 129 อุดรธานี Udonthani Hospital 19 22 28 112 26 57 29 30 130 ศรีนครินทร ม.ขอนแกน Srinakarin Hospital, Khon Kaen University 0000000 31 131 หนองคาย Nongkhai Hospital 0000000 32 132 ศิริราช Siriraj Hospital 1111010 Page 1 of 2 28 Jul 2008 September 2008 October 2008 November 2008 No Site No. Hospital Name Record Status Total Cases Total Cases Total Cases Total Records r Dirty Pending Final 33 133 กรุงเทพคริสเตียน The Bangkok Christian Hospital 0000000 34 134 เซนตหลุยส Saint Louis Hospital 0000000 35 135 ราชวิถี Rajavithi Hospital 0000000 36 136 ภูมิพลอดุลยเดช Bhumipol Hospital 0227115 37 137 คายจิรประวัติ นครสวรรค Jiraprawat Military Camp 0000000 38 138 มหาราชนครราชสีมา นครราชสีมา Maharajnakornrajasima Hospital 445205114 39 139 นครปฐม Nakhonpathom Hospital 6884617 28 1 40 140 อนันทมหิดล ลพบุรี Anandamahidol Hospital (Lopburi) 0016006 41 141 วชิรภูเก็ต ภูเก็ต Vachira Phuket Hospital 455300300 42 142 มูลนิธิโรคไต ณ พระตําหนักจิตรลดารโหฐาน The Nephology Foundation at Jidlada 22211803 43 143 50 พรรษา มหาวชิราลงกรณ 50-Years Mahavachiralongkorn Hospital 0000000 44 144 กลาง Klang Hospital 0000000 45 145 พระมงกุฎเกลา (อายุรกรรม) Phramongkutklao (Med) Hospital 0000000 46 146 หัวเฉียว Hua Chiew Hospital 0000000 47 147 ม.นเรศวร พิษณุโลก Naresuan University Hospital 0000000 48 148 พระพุทธชินราช พิษณุโลก Buddhachinaraj Hospital 003120012 49 149 ขอนแกน Khon Khen Hospital 0014103 50 150 สนามจันทร นครปฐม Sanamchan Hospital 0000000 51 151 คายประจักษศิลปาคม อุดรธานี Fort of Phrachaksilapakhom 0000000 52 152 คายสรรพสิทธิประสงค อุบลราชธานี Fort of Sapphasithiprasong 0113120 53 153 เจริญกรุงประชารักษ Charoenkrung Pracharak Hospital 03312408 54 154 ขอนแกน-ราม Khon Kaen-Ram Hospital 0013003 55 155 ราชพฤกษ ขอนแกน Ratchaphruek Hospital 0000000 56 156 มหาราชนครเชียงใหม เชียงใหม Maharaj Nakorn Chiang Mai Hospital 0000000 57 157 คายสุรนารี นครราชสีมา Suranaree Army Hospital 00310055 58 158 พระนั่งเกลา นนทบุรี Pranungklao Hospital 03312228 59 159 หาดใหญ Hat Yai Hospital 0000000 60 160 สมุทรสาคร Samutsakorn Hospital 044195014 Total 82 126 167 702 128 285 289 *Case is count from any CRF form were entered to database. **Data was accumulated until 2 December 2008 Page 2 of 2 28 Jul 2008.
Recommended publications
  • Cover Tjs 35-4-57
    ISSN 0125-6068 TheThai Journal of SURGERY Official Publication of the Royal College of Surgeons of Thailand www.surgeons.or.th/ejournal Volume 35 October-December 2014 Number 4 ORIGINAL ARTICLES 121 Comparison between Ventriculoatrial Shunt and Ventriculoperitoneal Shunt: Revision Rate and Complications Korrapakc Wangtanaphat, Porn Narischart 126 Open Surgical Management of Atherosclerotic Aortoiliac Occlusive Diseases (AIOD) Type 1 Anuwat Chantip 130 “Sawanpracharak” Connector: A Single Tube Intercostal Drainage Connector Wanchai Manakijsirisuthi 134 The Trainee’s Operative Experiences for General Surgery in Thailand Potchavit Aphinives CASE REPORT 139 Mitral and Tricuspid Valve Replacement in Uncommon Case of Situs Inversus with Dextrocardia Nuttapon Arayawudhikul, Boonsap Sakboon, Jareon Cheewinmethasiri, Angsu Chartirungsun, Benjamaporn Sripisuttrakul ABSTRACTS 143 Abstracts of the 39th Annual Scientific Congress of the Royal College of Surgeons of Thailand, 10-13 July 2014, Ambassador City Jomtien Hotel, Jomtien, Pattaya, Cholburi, Thailand (Part II) 169 Index Secretariat Office : Royal Golden Jubilee Building, 2 Soi Soonvijai, New Petchaburi Road, Huaykwang, Bangkok 10310, Thailand Tel. +66 2716 6141-3 Fax +66 2716 6144 E-mail: [email protected] www.surgeons.or.th The THAI Journal of SURGERY Official Publication of the Royal College of Surgeons of Thailand Vol. 35 October - December 2014 No. 4 Original Article Comparison between Ventriculoatrial Shunt and Ventriculoperitoneal Shunt: Revision Rate and Complications Korrapakc Wangtanaphat, MD Porn Narischart, MD Prasat Neurological Institute, Department of Medical Services, Ministry of Pubic Health, Bangkok, Thailand Abstract Background and Objective: Hydrocephalus is a common problem in neurosurgical field. In current clinical practice guidelines, ventriculoatrial shunt and ventriculoperitoneal shunt are recommended treatment options. No previous study reported differences between two procedures in term of complications and revision rates.
    [Show full text]
  • Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveilla
    applyparastyle “fig//caption/p[1]” parastyle “FigCapt” View metadata, citation and similar papers at core.ac.uk brought to you by CORE Open Forum Infectious Diseases provided by Apollo MAJOR ARTICLE Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveillance System Viriya Hantrakun,1, Somkid Kongyu,2 Preeyarach Klaytong,1 Sittikorn Rongsumlee,1 Nicholas P. J. Day,1,3 Sharon J. Peacock,4 Soawapak Hinjoy,2,5 and Direk Limmathurotsakul1,3,6, 1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 2 Epidemiology Division, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, 3 Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford, United Kingdom, 4 Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 5 Office of International Cooperation, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, and 6 Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Background. National notifiable diseases surveillance system (NNDSS) data in developing countries are usually incomplete, yet the total number of fatal cases reported is commonly used in national priority-setting. Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is largely underrecognized by policy-makers due to the underreporting of fatal cases via the NNDSS. Methods. Collaborating with the Epidemiology Division (ED), Ministry of Public Health (MoPH), we conducted a retrospec- tive study to determine the incidence and mortality of melioidosis cases already identified by clinical microbiology laboratories nationwide. A case of melioidosis was defined as a patient with any clinical specimen culture positive for B.
    [Show full text]
  • Acute Poisoning Surveillance in Thailand: the Current State of Affairs and a Vision for the Future
    Hindawi Publishing Corporation ISRN Emergency Medicine Volume 2013, Article ID 812836, 9 pages http://dx.doi.org/10.1155/2013/812836 Review Article Acute Poisoning Surveillance in Thailand: The Current State of Affairs and a Vision for the Future Jutamas Saoraya1 and Pholaphat Charles Inboriboon2 1 Emergency Department, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand 2 Department of Emergency Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA Correspondence should be addressed to Jutamas Saoraya; [email protected] Received 17 October 2013; Accepted 19 November 2013 Academic Editors: A. Eisenman, C. R. Harris, and O. Karcioglu Copyright © 2013 J. Saoraya and P. C. Inboriboon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Acute poisoning is a major public health threat worldwide, including Thailand, a country in Southeast Asia with over 67 million inhabitants. The incidence and characteristics of poisoning in Thailand vary greatly depending on the reporting body. This systematic review aims to provide a comprehensive description of the state of poisoning in Thailand. It identifies common trends and differences in poisoning by reporting centers and regional studies. Almost half of the cases and three-fourths of the deaths involved pesticide poisonings associated with agricultural occupations. However, increasing urbanization has led to an increase in drug and household chemical poisoning. Though the majority of reported poisonings remain intentional, a trend towards unintentional poisonings in pediatric and geriatric populations should not be dismissed.
    [Show full text]
  • In Vitro Activity of Biapenem and Comparators Against Multidrug
    Pharmaceutical Sciences Asia Pharm Sci Asia 2020; 47 (4), 378-386 DOI:10.29090/psa.2020.04.019.0072 Research Article In vitro activity of biapenem and comparators against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii isolated from tertiary care hospitals in Thailand Jantana Houngsaitong1, Preecha Montakantikul1, Taniya Paiboonwong1, ABSTRACT 2 Mullika Chomnawang , Acinetobacter baumannii is one of nosocomial pathogen 2 Piyatip Khuntayaporn , which emerges as multidrug-resistance worldwide. Multidrug- 1* Suvatna Chulavatnatol resistant A. baumannii (MDRAB) and carbapenem-resistant A. baumannii (CRAB) are highly concerned due to limitation of 1 Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand therapeutic options. Antibacterial activity of biapenem was explored 2 Department of Microbiology, Faculty of in order to overcome bacterial resistance. A total of 412 A. baumannii Pharmacy, Mahidol University, Bangkok, Thailand clinical isolates from 13 tertiary care hospitals in Thailand were collected. MIC values of biapenem and comparators; imipenem, meropenem, colistin, sulbactam, ciprofloxacin ceftazidime and *Corresponding author: fosfomycin sodium, were determined by broth microdilution Suvatna Chulavatnatol [email protected] method in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines (2016). In total, 320 isolates (77.67%) were MDRAB and 328 isolates (79.61%) were CRAB while 58 isolates (14.07%) were colistin-resistant AB. A. baumannii showed widespread resistance to ceftazidime, ciprofloxacin KEYWORDS: and carbapenems in more than 90% of the strains; resistance to Biapenem; Multidrug-resistant A. sulbactam, fosfomycin, and colistin were 85%, 60%, and 15% Baumannii; Carbapenem-resistant respectively. By comparison among carbapenems, biapenem showed MIC of 16/32 which were at least 2 folds lower A.
    [Show full text]
  • ASSOCIATED GENES, and GENOTYPE of METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS Clinical ISOLATES from NORTHERN THAILAND
    SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH ANTIBIOGRAM, ANTIBIOTIC AND DISINFECTANT RESISTANCE GENES, BIOFILM-PRODUCING AND -ASSOCIATED GENES, AND GENOTYPE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CLINIcaL ISOLATES FROM NORTHERN THAILAND Rathanin Seng1, Thawatchai Kitti2, Rapee Thummeepak3, Autchasai Siriprayong3, Thitipan Phukao3, Phattaraporn Kongthai3, Thanyasiri Jindayok4, Kwanjai Ketwong5, Chalermchai Boonlao6 and Sutthirat Sitthisak3,7 1Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok; 2Faculty of Oriental Medicine, Chiang Rai College, Chiang Rai; 3Department of Microbiology and Parasitology, Faculty of Medical Science, 4Division of Clinical Pathology, Faculty of Medicine, Naresuan University, Phitsanulok; 5Sawanpracharak Hospital, Amphoe Meuang, Nakhon Sawan; 6Chiang Rai Prachanukroh Hospital, Amphoe Meuang, Chiang Rai; 7Centre of Excellence in Medical Biotechnology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand Abstract. Methicillin-resistant Staphylococcus aureus (MRSA) causes a variety of infectious diseases in both hospital and community. The study determined preva- lence of antibiotic resistance and associated genes, biofilm-producing phenotype and associated genes, SCCmec types, and clonal subtype ST239 of MRSA clinical isolates obtained from three hospitals in northern Thailand during January 2013 to October 2015. Some 95% of MRSA isolates were multidrug resistant, with 82%, 60% and 47% harboring ermA, ermB and qacAB, respectively. Although all MRSA isolates were positive for slime (biofilm) production on Congo red agar, quan- titative measurement of biofilm generation using microtiter plate assay (MTP) indicated 60% were low biofilm producers, with prevalence of biofilm-associated genes, bab, cna, fnbA, and icaAD, ranging from 50% to 100%. MRSA SCCmec type III was predominant, but the presence of SCCmec type IV and type V (albeit at low frequency) indicated acquisition of community-acquired infection.
    [Show full text]
  • Risk Prediction Score of Death in Traumatised and Injured Children
    RISK PREDICTION SCORE OF DEATH IN TRAUMATISED AND INJURED CHILDREN SAKDA ARJ-ONG VALLIPAKORN A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (CLINICAL EPIDEMIOLOGY) FACULTY OF GRADUATE STUDIES MAHIDOL UNIVERSITY 2013 COPYRIGHT OF MAHIDOL UNIVERSITY Thesis entitled RISK PREDICTION SCORE OF DEATH IN TRAUMATISED AND INJURED CHILDREN ............................................................ Mr.Sakda Arj-ong Vallipakorn Candidate ............................................................ Asst.Prof.Ammarin Thakkinstian, Ph.D. Major advisor ............................................................. Prof.Paibul Suriyawongpaisal, M.D., M.Sc. Co-advisor ............................................................ Assoc.Prof.Adisak Plitapolkarnpim, M.D., M.P.H. Co-advisor ......................................................... ............................................................ Prof.Banchong Mahaisavariya, M.D., Asst.Prof. Dr.Ammarin Thakkinstian, Ph.D. Dip Thai Board of Orthopedics Program Director Dean Doctor of Philosophy Program in Faculty of Graduate Studies Clinical Epidemiology Mahidol University Faculty of Medicine, Ramathibodi Hospital Mahidol University Thesis entitled RISK PREDICTION SCORE OF DEATH IN TRAUMATISED AND INJURED CHILDREN was submitted to the Faculty of Graduate Studies, Mahidol University for the degree of Doctor of Philosophy (Clinical Epidemiology) on July 4,2013 ………………………………………. Mr.Sakda Arj-ong Vallipakorn Candidate ………………………………………. Lect.Vijj Kasemsup,
    [Show full text]
  • วารสารวิจัยและนวัตกรรมทางสุขภาพ Journal of Health Research and Innovation
    วิทยาลัยพยาบาลบรมราชชนนี สุราษฎร์ธานี The Conducting of Self-Help Group in Adolescents with Cancer: Nurses’ Roles วารสารวิจัยและนวัตกรรมทางสุขภาพ Journal of Health Research and Innovation ปี ที ่ 3 ฉบับที ่ 2 กรกฎาคม – ธันวาคม 2563 วัตถุประสงค์ 1. เพื่อเผยแพร่ผลงานวิจัย บทความทางวิชาการและนวัตกรรมทางสุขภาพของอาจารย์ บุคลากร นักศึกษา วิทยาลัยพยาบาลบรมราชชนนี สุราษฎร์ธานี ในด้านการแพทย์ การพยาบาล การสาธารณสุข การศึกษาใน สาขาวิทยาศาสตร์สุขภาพ และด้านอื่น ๆ ที่เกี่ยวข้องกับวิทยาศาสตร์สุขภาพ 2. เพื่อเผยแพร่ผลงานวิจัย บทความทางวิชาการและนวัตกรรมทางสุขภาพของบุคลากรทางการแพทย์ นักวิชาการผู้ปฏิบัติงานในศาสตร์ที่เกี่ยวข้องตลอดจนศิษย์เก่า และผู้สนใจ ในด้านการแพทย์ การพยาบาล การสาธารณสุข การศึกษาในสาขาวิทยาศาสตร์สุขภาพ และด้านอื่น ๆ ที่เกี่ยวข้องกับวิทยาศาสตร์สุขภาพ 3. เพื่อสร้างเครือข่ายทางวิชาการทั้งในวิทยาลัยพยาบาลบรมราชชนนี สุราษฎร์ธานี และสถาบันวิชาชีพ ที่เกี่ยวข้อง 4. เพื่อตอบสนองพันธกิจหลักในการสร้างองค์ความรู้และการเผยแพร่ผลงานวิชาการและงานวิจัยของ วิทยาลัยพยาบาลบรมราชชนนี สุราษฎร์ธานี สำนักงำน บรรณาธิการวารสาร วิทยาลัยพยาบาลบรมราชชนนี สุราษฎร์ธานี 56/6 หมู่ 2 ถ.ศรีวิชัย ตาบล มะขามเตี้ย อาเภอเมือง จังหวัดสุราษฎร์ธานี 84000 โทร. 0-7728-7816 ต่อ 218 โทรสาร 0-7727-2571 http://www.bcnsurat.ac.th E-mail: [email protected] พมิ พท์ ี่ โรงพิมพ์เลิศไชย 16/4-6 ถนนไตรอนสุ นธิ์ ตาบลตลาด อาเภอเมืองสุราษฎร์ธานี จังหวัดสุราษฎร์ธานี โทรศัพท์ 0 7727 3973 โทรสาร 0 7729 9521 วารสารวจิ ยั และนวตั กรรมทางสขุ ภาพ เป็นวารสารทมี่ ผี ูท้ รงคณุ วฒุ ติ รวจสอบเนอื้ หาบทความเพอื่ ลงตพี มิ พจ์ า นวน 2 ท่านต่อบทความ และ บทความหรอื ขอ้ คดิ เหน็ ใด ๆ ทปี่ รากฏในวารสารวจิ
    [Show full text]
  • HEALTHQUAL International Update
    HEALTHQUAL International Update HAITI BOTSWANA ZAMBIA NIGERIA GUYANA SWAZILAND ZIMBABWE USA THAILAND UGANDA MOZAMBIQUE NAMIBIA KENYA RWANDA VIETNAM PAPUA NEW GUINEA 1995 2003 2005 2006 2007 2008 2009 2010 2012 BRIEF VOLUME I, ISSUE I The following HEALTHQUAL Brief is the first in a four part series addressing quality improvement in tuberculosis care and treatment. Tuberculosis: Improving Care and Treatment Through Quality Improvement UGANDA Kumi Hospital This review demonstrated that TB assessment was consis- Kumi Hospital, a rural, not-for-profit facility and the national tently recorded in more than 90% of all charts. referral hospital for TB in eastern Uganda, is located almost 200 miles from the capital city of Kampala. With a 350 bed Performance rates for TB assessment subsequently in- capacity, Kumi has become a destination for the region’s creased from 35% at baseline, to 85% at round two data most vulnerable individuals, providing a wide-variety of collection. clinical services from primary care to TB. % of Patients Assessed for Tuberculosis (two rounds) At baseline, staff discovered that only 35% of eligible pa- tients were assessed for TB, defined by a clinical symptom screen based on national guidelines. Round 1 n=80 35% Uganda guidelines recommend TB symptom screening for the existence of a cough for more Round 2 n=94 85% than three weeks, weight loss, hemoptysis, night sweats, and evening fevers. 0% 20% 40% 60% 80% 100% These findings compelled a series of improvement activities Source: Kumi Hospital undertaken to improve performance in this area of care. Performance improvement in TB assessment has compelled First, hospital personnel established a designated TB staff ongoing investigation in other areas.
    [Show full text]
  • Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveilla
    applyparastyle “fig//caption/p[1]” parastyle “FigCapt” Open Forum Infectious Diseases MAJOR ARTICLE Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveillance System Viriya Hantrakun,1, Somkid Kongyu,2 Preeyarach Klaytong,1 Sittikorn Rongsumlee,1 Nicholas P. J. Day,1,3 Sharon J. Peacock,4 Soawapak Hinjoy,2,5 and Direk Limmathurotsakul1,3,6, 1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 2 Epidemiology Division, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, 3 Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford, United Kingdom, Downloaded from https://academic.oup.com/ofid/article-abstract/6/12/ofz498/5629151 by guest on 01 June 2020 4 Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 5 Office of International Cooperation, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, and 6 Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Background. National notifiable diseases surveillance system (NNDSS) data in developing countries are usually incomplete, yet the total number of fatal cases reported is commonly used in national priority-setting. Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is largely underrecognized by policy-makers due to the underreporting of fatal cases via the NNDSS. Methods. Collaborating with the Epidemiology Division (ED), Ministry of Public Health (MoPH), we conducted a retrospec- tive study to determine the incidence and mortality of melioidosis cases already identified by clinical microbiology laboratories nationwide. A case of melioidosis was defined as a patient with any clinical specimen culture positive for B.
    [Show full text]
  • Education Bangkok Insurance Scholarship Project
    VISION Bangkok Insurance aims to be the preferred non-life insurer in Thailand We will strive to progress with: • Quality products and services that meet our customers’ needs • Fast and responsive service to maximize our customers’ satisfactions • Exceptional personnel with superior the insurance expertise • Tradition and culture of corporate integrity 2 CONTENTS VISION 2 FINANCIAL HIGHLIGHTS 5 PRIDE IN 2017 6 MESSAGE FROM THE CHAIRMAN OF THE ADVISORY BOARD 8 MESSAGE FROM THE CHAIRMAN 10 REPORT OF THE COMPANY’S OPERATIONS 13 INVESTMENT INCOME 18 INVESTMENT 19 INVESTMENTS IN SECURITIES 20 SHAREHOLDING IN OTHER COMPANIES 21 REVENUE STRUCTURE 22 SUMMARY OF QUARTERLY FINANCIAL RESULTS 23 FIVE YEARS REVIEW 24 POLICY ON AND THE OVERALL BUSINESS TRANSACTION 26 TYPE OF BUSINESS TRANSACTIONS 30 RISK FACTORS 37 ADVISORY BOARD 43 BOARD OF DIRECTORS AND BOARD OF DIRECTORS PROFILE 44 MANAGEMENT COMMITTEE AND MANAGEMENT COMMITTEE PROFILE 52 CORPORATE SOCIAL RESPONSIBILITY 61 REPORT OF THE AUDIT COMMITTEE 82 REPORT OF THE REMUNERATION AND NOMINATION COMMITTEE 83 REPORT OF THE CORPORATE GOVERNANCE COMMITTEE 84 REPORT ON THE BOARD OF DIRECTOR’S RESPONSIBILITY FOR FINANCIAL STATEMENTS 85 REPORT OF INDEPENDENT AUDITOR 86 STATEMENTS OF FINANCIAL POSITION 90 STATEMENTS OF COMPREHENSIVE INCOME 92 STATEMENTS OF CASH FLOWS 94 STATEMENTS OF CHANGES IN OWNERS’ EQUITY 96 NOTES TO FINANCIAL STATEMENTS 98 COMPANY’S FINANCIAL STATUS 144 FINANCIAL RATIO 148 RELATED PARTIES TRANSACTIONS 149 ORGANIZATION STRUCTURE 151 MANAGEMENT STRUCTURE 152 SHAREHOLDINGS STRUCTURE 161
    [Show full text]
  • The Thai Journal of Orthopaedic Surgery
    The Thai Journal Of Orthopaedic Surgery The Official Journal of the Royal College of Orthopaedic Surgeons of Thailand ISSN 0125-7552 Volume 37 / Number 1 January 2013 The Council Members of the Royal College of Orthopaedic Surgeons of Thailand (RCOST) 2012-2014 President Thavat Prasartritha, MD Immediate Past President Adisorn Patradul, MD President Elect Sukit Saengnipanthkul, MD 1st Vice-President Banchong Mahaisavariya, MD 2nd Vice-President Aree Tanavalee, MD Registrar Chumroonkiet Leelasestaporn, MD Treasurer Thawee Songpatanasilp, MD Secretary General Keerati Chareancholvanich, MD Assistant Secretary General Charlee Sumettavanich, MD Promotion Thana Turajane, MD Council Members Sumroeng Neti, MD Pijaya Nagavajara, MD. Kanyika Chanmiprasas, MD Preecha Chalidapong, MD Warat Tassanawipas, MD Chiroj Sooraphanth, MD Thipachart Bunyaratabandhu, MD Advisory Board Samak Bukkanasen, MD Natee Rukpollamuang, MD Direk Israngkul, MD Suprija Mokkhavesa, MD Charoen Chotigavanich, MD Vinai Parkpian, MD Pongsak Vathana, MD Prasit Gonggetyai, MD Chaithavat Ngarmukos, MD Thamrongrat Keokarn, MD Suthorn Bavonratanavech, MD Wichien Laohacharoensombat, MD Saranatra Waikakul, MD ราชวิทยาลัยแพทย์ออร์โธปิดิกส์แห่งประเทศไทย The Royal College of Orthopaedic Surgeons of Thailand ขอเรียนเชิญแพทย์และผู้สนใจเข้าร่วมฟังการบรรยาย วันอาทิตย์ที่ 20 ตุลาคม 2556 เวลา 11.30-13.00 น. Interactive workshop: งานวิจัยส าหรับการขอกา หนดต าแหน่งนายแพทย์เชี่ยวชาญ 11.30 - 11.40 ปัญหาหนักใจใน ซี 9 11.40 - 12.00 ช่วยอยา่ งไร...ทา ไมไม่ได ้ กรรมการ Research Section 12.00 - 12.40
    [Show full text]
  • In Vitro Activities of Colistin and Sitafloxacin Combinations Against
    antibiotics Article In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods Vipavee Rodjun 1, Jantana Houngsaitong 2,*, Preecha Montakantikul 2, Taniya Paiboonvong 3, Piyatip Khuntayaporn 2 , Pattareeya Yanyongchaikit 2 and Pusana Sriyant 2 1 Faculty of Pharmacy, Siam University, Bangkok 10160, Thailand; [email protected] 2 Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand; [email protected] (P.M.); [email protected] (P.K.); [email protected] (P.Y.); [email protected] (P.S.) 3 Faculty of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-2644-8694 Received: 4 June 2020; Accepted: 11 August 2020; Published: 14 August 2020 Abstract: Drug-resistant Acinetobacter baumannii (A. baumannii) infections are a critical global problem, with limited treatment choices. This study aims to determine the in vitro activities of colistin–sitafloxacin combinations against multidrug-, carbapenem- and colistin-resistant A. baumannii (MDR-AB, CRAB, CoR-AB, respectively) clinical isolates from tertiary care hospitals. We used the broth microdilution checkerboard and time-kill methods in this study. Synergy was found using both methods. The colistin–sitafloxacin combination showed synergy in MDR-AB, CRAB, and CoR-AB isolates (3.4%, 3.1%, and 20.9%, respectively). No antagonism was found in any type of drug-resistant isolate. The majority of CoR-AB isolates became susceptible to colistin (95.4%). The time-kill method also showed that this combination could suppress regrowth back to the initial inocula of all representative isolates.
    [Show full text]